Biosimilars, GLP-1s, and Stop-loss: Topics Benefit Advisors Need to Consider in Q3 2023 6 min readJune 28, 2023
After 20 Years of Humira Prescriptions, Therapeutic Interchange Programs Give Employers Much-Needed Options 5 min readJune 14, 2023